Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
about
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkinGene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian modelsParkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's diseaseParkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6Animal models of Parkinson's disease: vertebrate geneticsBehavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.Identification and characterization of a novel endogenous murine parkin mutation.Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.Transgenic animal models of neurodegeneration based on human genetic studies.Microarrays in Parkinson's disease: a systematic approach.Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.Parkin deficiency increases vulnerability to inflammation-related nigral degenerationUbiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.The role of parkin in familial and sporadic Parkinson's disease.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.Oxidative stress in genetic mouse models of Parkinson's disease.Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases.Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain.Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.Comparative analysis of Parkinson's disease-associated genes reveals altered survival and bioenergetics of parkin-deficient dopamine neurons in mice.PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect
P2860
Q24298771-84C02EFA-8AE9-4AB4-B30B-258ACF78DB80Q26863375-5DE6C270-6864-427C-A09E-F40AE9529D2FQ27340039-5672FE7B-BD64-46ED-9784-4DD35C902FC5Q28397050-12A3755F-5A76-42AC-9A50-845804A06BACQ30429583-5616F22E-A0C3-4A7C-A1E6-04472BD854F3Q30444939-C5F595CF-F01B-41DC-A7DA-F33FB5D8ACEAQ30502685-8233D8B0-49C5-4E50-A0DA-1413C7215F1AQ34012526-FBF3E66B-C36A-448E-BA71-2E358A5B3FE1Q34448273-1BAC443E-FAC0-4098-9B18-E169730F7DE7Q34890228-D92EFBE7-F630-452F-9B7F-5486B0A28D3AQ36525157-5FC070A3-4498-4745-9F2B-0A9B90D76D5EQ36553302-34487B2E-DA81-4C4A-B0CE-64B30952B0C0Q37015945-B32FC813-1315-4D4E-AD14-9C4B5ED8E84AQ37027500-1C4C7AB8-84A2-4625-8660-48D8E18B2A95Q37348548-DD5D90CF-D414-4073-952D-F44A103CC329Q37509682-5F8423FC-08FF-46BF-AA61-EBEA780F8E12Q37699215-52CCC684-5724-4B1A-8651-76B6A7550A01Q38021865-99850560-1EFD-49DD-8B6E-E6340AE3AF9CQ38029327-6FEBF3BE-061D-4160-B0F4-48172952CB0DQ38584748-F0465674-A63C-4AC4-8926-5B66F5FFB7B9Q39284027-DAA8429B-04F4-4565-9A8A-9F012F1608E0Q41515438-21C8827A-10DA-4E32-B9CA-630E1AAEC518Q43139168-E7B0A9BF-B141-4932-A983-08E58DD265BAQ51066799-DDA250DE-0221-45DD-B379-B5C51ABDB718Q52924863-EE2B695D-6024-4730-AB37-5D809E7736DEQ53071097-AAC4B442-6341-41FA-AA01-D97D3F566E89Q58478955-E7FDE600-277E-411B-85B5-D1F7B154414D
P2860
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@ast
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@en
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@nl
type
label
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@ast
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@en
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@nl
prefLabel
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@ast
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@en
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@nl
P2093
P2860
P356
P1433
P1476
Parkin-deficient mice are not ...... methamphetamine neurotoxicity
@en
P2093
Francisco A Perez
Richard D Palmiter
Wendy R Curtis
P2860
P2888
P356
10.1186/1471-2202-6-71
P407
P577
2005-12-24T00:00:00Z
P5875
P6179
1018511247